As shown in Figure 10, besides HNSCC, the expression of PPAP2B is decreased significantly in several cancer types, including the cancer of the urinary bladder, colon, esophagus, liver, pancreas, cholangiocarcinoma, lung adenocarcinoma, and lung squamous cell carcinoma. Here, PLPP3 is linked to cholangiocarcinoma.